Company Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.
It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.
It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services.
The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities.
ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
| Country | United States |
| Founded | 1984 |
| IPO Date | Mar 31, 1992 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 15,000 |
| CEO | Vivek Jain |
Contact Details
Address: 951 Calle Amanecer San Clemente, California 92673 United States | |
| Phone | 949 366 2183 |
| Website | icumed.com |
Stock Details
| Ticker Symbol | ICUI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000883984 |
| CUSIP Number | 44930G107 |
| ISIN Number | US44930G1076 |
| Employer ID | 33-0022692 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Vivek Jain | Chief Executive Officer and Chairman of the Board |
| Daniel Woolson | President |
| Brian Michael Bonnell | Chief Financial Officer and Treasurer |
| Christian B. Voigtlander | Chief Operating Officer |
| Virginia Ruth Sanzone | Corporate Vice President, General Counsel, Secretary and Compliance Officer |
| Ben Sousa | Chief Information Officer |
| Olivia Barrall | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2025 | SD | Form - SD |
| May 30, 2025 | 144 | Filing |
| May 19, 2025 | 144 | Filing |
| May 15, 2025 | 144 | Filing |
| May 14, 2025 | 144 | Filing |
| May 14, 2025 | 8-K | Current Report |
| May 13, 2025 | 144 | Filing |
| May 8, 2025 | 10-Q | Quarterly Report |
| May 8, 2025 | 8-K | Current Report |
| May 7, 2025 | SCHEDULE 13G/A | Filing |